Philips sleep apnea machines, which have been recalled and linked to 500 deaths, are now the subject of a $400 million plus ...

A group of over 100 institutional investors have written to Dutch medical technology company Philips demanding compensation of €800 million for “significant losses to shareholders” over the sleep ...

This is not the only recall the company is dealing with. Philips’ Respironics business has been facing issues with some of its sleep apnea products since June 2021 when it issued a recall of 15 ...

The Class I recall, the FDA’s severest classification, is a correction and does not require removing devices from where they are used or sold. Philips started the recall on Nov. 20, 2024 ...

Starting in 2021, Philips launched a series of product recalls affecting its Respironics range of ventilators and other respiratory machines; most recently, a Class I recall of around 63,000 ...

Philips is recalling the software associated with its mobile cardiac outpatient telemetry devices after 109 patient injuries and two patient deaths, a Jan. 13 FDA recall notice said. The software ...

During its first-quarter earnings report this spring, Philips, the health technology company, announced it agreed to pay $1.1 billion in a settlement over respiration and sleep apnea machines.

Philips Respironics announced that it agreed to pay over a billion dollars to settle claims stemming from the 2021 U.S. recall of its sleep therapy devices. Philips put over 12,800 Philips Avent ...